Brown discharge after menopause is old blood leaving the body slowly, and stopping it depends entirely on what’s causing it. The most common cause is vaginal atrophy, the thinning and drying of vaginal tissue that happens when estrogen levels drop. But brown discharge can also signal polyps, infections, hormone therapy side effects, or, in about 9% of cases, uterine cancer. Any vaginal bleeding or discharge that occurs more than a year after your last period needs evaluation, even if it only happens once.
Why Brown Discharge Happens After Menopause
Brown discharge is simply blood that has oxidized before leaving your body. It moves slowly enough through the vaginal canal to turn from red to brown. After menopause, several things can trigger this bleeding in the first place.
The most frequent culprit is vaginal atrophy. Without estrogen, the vaginal lining loses thickness, blood flow, elasticity, and its natural moisture. The tissue becomes pale and fragile. Even minor friction from daily activity, wiping, or sexual intercourse can cause small amounts of bleeding that show up as brown spotting. This is part of a broader condition called genitourinary syndrome of menopause, which also includes dryness, burning, and urinary symptoms.
Other common causes include uterine polyps (noncancerous growths inside the uterus that bleed when their blood supply becomes congested), endometrial hyperplasia (a thickening of the uterine lining that can contain abnormal cells), and hormone replacement therapy. If you recently started or changed HRT, breakthrough spotting is common and often resolves within six months.
Infections and pH Changes
Menopause shifts the vaginal environment in ways that make infections more likely. Estrogen loss raises vaginal pH and depletes the protective bacteria (lactobacilli) that normally keep harmful organisms in check. This creates conditions favorable for bacterial vaginosis and other infections that can cause discharge, irritation, and odor.
Bacterial vaginosis typically produces a thin, grayish-white discharge with a fishy smell rather than brown spotting, but the two conditions can overlap. Distinguishing between atrophy-related discharge and infection-related discharge can be tricky because both involve irritation and elevated pH. If your discharge has a noticeable odor or unusual color beyond brown spotting, an infection is worth investigating.
How Cancer Risk Is Evaluated
About 9% of women with postmenopausal bleeding are ultimately diagnosed with endometrial cancer. That means roughly 91% have a benign cause, but the 9% figure is significant enough that any postmenopausal bleeding warrants a medical workup. Notably, about 90% of women who do have uterine cancer experienced vaginal bleeding before their diagnosis, making it an important early warning sign.
The initial evaluation typically involves a transvaginal ultrasound to measure the thickness of your uterine lining. If the lining measures 4 millimeters or less, the chance of endometrial cancer is extremely low, with a negative predictive value greater than 99%. If the lining is thicker than 4 mm, or if the ultrasound can’t get a clear image, the next step is usually an endometrial biopsy, a tissue sample taken from the uterine lining.
One important detail: even a thin lining doesn’t rule out every type of uterine cancer. Certain rarer forms can develop with lining thickness under 3 mm. If brown discharge keeps coming back or doesn’t stop, a tissue biopsy is recommended regardless of what the ultrasound showed.
Treating Vaginal Atrophy
If atrophy is the cause, the goal is to restore moisture, thickness, and resilience to vaginal tissue. There are both hormonal and non-hormonal approaches.
Low-dose vaginal estrogen is the most effective treatment. It comes in several forms: a cream applied inside the vagina, a small tablet inserted vaginally, or a flexible ring that stays in place for three months and releases estrogen slowly. These deliver estrogen directly to the tissue rather than throughout your whole body, which keeps systemic absorption very low. Most women notice improvement in dryness, fragility, and spotting within a few weeks of consistent use.
If you prefer to avoid hormones, non-hormonal vaginal moisturizers are considered a first-line option. The most effective formulations are oil-in-water creams that contain both water and skin-soothing lipids, since the vaginal lining is a layered tissue that benefits from both hydration and a protective fat barrier. Look for products with a pH around 4.5 (close to the vagina’s natural acidity) and low osmolality, meaning they won’t pull moisture out of tissue. These are used regularly, not just before intercourse, to maintain tissue hydration over time. Water-based lubricants help reduce friction during sex but don’t treat the underlying tissue changes the way a moisturizer does.
Addressing Other Causes
Uterine polyps that cause bleeding are typically removed through hysteroscopy, a minimally invasive procedure where a thin camera is inserted through the cervix. Small polyps under 10 mm that aren’t causing symptoms have a high chance of shrinking on their own within a year, and the risk of them being cancerous is low. But polyps causing active spotting or discharge are generally removed to stop the bleeding and to examine the tissue.
If hormone replacement therapy is behind the spotting, the solution may be as simple as adjusting the dose or type of hormone. Spotting that starts when you begin HRT or change your regimen often settles down within six months without any intervention. If it persists beyond that window, your prescriber may need to reassess.
Infections like bacterial vaginosis are treated with targeted antibiotics. Restoring the vaginal microbiome afterward, whether through vaginal estrogen or pH-balanced moisturizers, can help prevent recurrence by supporting the return of protective bacteria.
What the Workup Looks Like
When you report brown discharge to your provider, the evaluation usually follows a predictable path. A pelvic exam comes first to check for visible irritation, polyps on the cervix, or signs of infection. A transvaginal ultrasound measures endometrial thickness. If the lining is thin and the exam points toward atrophy, treatment can begin without further testing. If the lining is thick, if there’s a visible mass, or if you have risk factors for endometrial cancer (obesity, diabetes, a history of irregular periods before menopause, or tamoxifen use), an endometrial biopsy or hysteroscopy will likely follow.
The biopsy itself is a brief office procedure. A thin, flexible tube is passed through the cervix to collect a small tissue sample. It can cause cramping similar to a strong period cramp, but it’s over quickly. Results typically come back within a week or two and will either confirm a benign cause or identify abnormal cells that need further treatment.
If your brown discharge recurs after an initial normal evaluation, don’t assume the first result still applies. The American College of Obstetricians and Gynecologists recommends that repeated or ongoing postmenopausal bleeding should prompt a new tissue evaluation, even if a previous ultrasound showed a thin lining.